West Loop Innovations

West Loop Innovations is a healthcare-focused translational research company formed by University of Illinois Chicago and Deerfield Management to advance therapeutics originating from UIC laboratories. The organization provides funding, project selection, and drug development expertise intended to move academic discoveries toward Investigational New Drug readiness and eventual commercial biopharmaceutical development. Rather than operating as a conventional single-asset biotech, West Loop functions as a venture-style collaboration vehicle supporting multiple UIC-derived therapeutic projects across therapeutic areas. Publicly described work has included antibody-based approaches for autoimmune diseases, and the partnership has also highlighted interest in rare genetic diseases. The company appears to focus on early-stage discovery and preclinical translation rather than running late-stage clinical programs or commercial products.